Lilly Bamlanivimab Antibody Playbook

Lilly Bamlanivimab Antibody Playbook

This Antibody Playbook provides information for state, territorial and local public health programs.

This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.

Related Content

CHA Submits PAHPA Hearing Statement for the Record

CHA has submitted a statement for a Senate HELP Committee hearing to highlight how the national disaster and pandemic response infrastructure must prioritize children’s needs.

May 04, 2023

The Facts About COVID-19 and Children

Read the latest data on kids' COVID-19 cases, hospitalizations and vaccination numbers.

March 10, 2023

Creating a New Supply Chain for Continuous Albuterol

Children’s hospitals and their partners convene to ensure stable supply of albuterol for pediatric patients amid a critical shortage.

Feb. 21, 2023